VOGLI RAPID 0.3/2.0 (Repaglinide (2mg) + Voglibose (0.3mg))

Vogli-Rapid 0.3/2.0 Tablets are a dual-action medication designed to assist individuals diagnosed with type 2 diabetes mellitus. This pharmaceutical aids in managing elevated blood glucose levels in the body, particularly after meals. It is especially beneficial when other medications and dietary restrictions have failed to adequately control high blood sugar levels. The administration of Vogli-Rapid should be aligned with meal times, specifically taken shortly after eating. The prescribing physician will determine the appropriate dosage tailored to the patient’s unique medical needs. It is imperative not to discontinue use without consulting a healthcare provider, as this could lead to increased blood sugar levels, which may result in severe complications such as renal impairment or vision problems. In the event of a missed dose, patients should refrain from taking the missed dose between meals; instead, they should wait until the next meal and take the medication at that time, without doubling the dose to compensate. This medication is intended to complement a comprehensive treatment regimen that includes dietary management, consistent physical activity, and weight loss initiatives as directed by a healthcare professional. Regular monitoring of blood glucose levels is essential during treatment. Prior to initiation, it is crucial to inform the healthcare provider of any pre-existing kidney or liver conditions, urinary tract infections, or the use of diuretics. Women who are pregnant or nursing should seek medical advice before starting this medication and should also avoid excessive alcohol consumption, as it may elevate the risk of experiencing side effects.